| Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN QU Ain, JY Chung, YH Kim Journal of Controlled Release 205, 120-127, 2015 | 168 | 2015 |
| Wnt signaling in the regulation of immune cell and cancer therapeutics M Haseeb, RH Pirzada, QU Ain, S Choi Cells 8 (11), 1380, 2019 | 96 | 2019 |
| TLR4-targeting therapeutics: structural basis and computer-aided drug discovery approaches Q Ain, M Batool, S Choi Molecules 25 (3), 627, 2020 | 94 | 2020 |
| Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance JY Chung, QU Ain, Y Song, SB Yong, YH Kim Genome research 29 (9), 1442-1452, 2019 | 69 | 2019 |
| Mononuclear phagocytes as a target, not a barrier, for drug delivery SB Yong, Y Song, HJ Kim, QU Ain, YH Kim Journal of Controlled Release 259, 53-61, 2017 | 45 | 2017 |
| RNAi-mediated silencing of TNF-α converting enzyme to down-regulate soluble TNF-α production for treatment of acute and chronic colitis Y Song, YR Kim, SM Kim, QU Ain, K Jang, CS Yang, YH Kim Journal of Controlled Release 239, 231-241, 2016 | 31 | 2016 |
| Gene delivery to the skin–how far have we come? QU Ain, EVR Campos, A Huynh, D Witzigmann, S Hedtrich Trends in Biotechnology 39 (5), 474-487, 2021 | 28 | 2021 |
| Amelioration of atherosclerotic inflammation and plaques via endothelial adrenoceptor-targeted eNOS gene delivery using redox-sensitive polymer bearing l-arginine QU Ain, H Chung, JY Chung, JH Choi, YH Kim Journal of Controlled Release 262, 72-86, 2017 | 27 | 2017 |
| COVID-19 highlights the model dilemma in biomedical research SH 1. Adhikary, P.P., Qurrat Ul Ain., Hocke, A.C. Nat Rev Mater, 2021 | 19 | 2021 |
| Enhanced Systemic Anti-Angiogenic siVEGF Delivery using PEGylated Oligo-D-Arginine YHK Jee Young Chung, Qurrat Ul Ain, Hyun-Lin Lee, So-Mi Kim Molecular Pharmaceutics 14 (9), 3059–3068, 2017 | 12 | 2017 |
| Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations Q Ul Ain, JH Lee, YS Woo, YH Kim Archives of Pharmacal Research 39, 1266-1274, 2016 | 10 | 2016 |
| Regeneration of anti-hypoxic myocardial cells by transduction of mesenchymal stem cell-derived exosomes containing Tat-metallothionein fusion proteins QU Ain, YS Woo, JY Chung, YH Kim Macromolecular Research 26 (8), 709-716, 2018 | 3 | 2018 |
| Gene/carrier complex for preventing or treating inflammatory diseases YH Kim, T Kim, CS Yang, S Yoonsung, J Chung, JO Sungsin, SM Kim, ... US Patent 10,709,793, 2020 | | 2020 |
| Current and Future Aspects of Smart Nanotheranostic Agents in Cancer QU Ain Nanotheranostics: Applications and Limitations, 213, 2019 | | 2019 |
| Studies on the Development of Targeted Gene Delivery Systems for Reversal of Atherosclerosis and obesity QU Ain 한양대학교, 2017 | | 2017 |
| Development of biodegradable electrospun nanofibers containing 17-AAG JY Chung, HL Lee, QU Ain, YS Song, YH Kim Journal of controlled release: official journal of the Controlled Release …, 2015 | | 2015 |
